Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
Vascular Medicine (London, England)|April 10, 2018
Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial executionR Kevin Rogers, William R Hiatt, Manesh R Patel, et al.
Journal of Clinical Medicine|May 25, 2024
Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US SampleBenjamin D Horne, Nipun Atreja, John Venditto, et al.
Trauma Surgery & Acute Care Open|June 16, 2020
Multicenter assessment of the Brain Injury Guidelines and a proposal of guideline modificationsAbid D Khan, Anna J Elseth, Jacqueline A Brosius, et al.
The American Surgeon|November 29, 2021
Whole Blood Versus Conventional Blood Component Massive Transfusion Protocol Therapy in Civilian Trauma PatientsJanet S Lee, Abid D Khan, Franklin L Wright, et al.
Journal of the American Heart Association|March 31, 2017
Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary InterventionJoseph M Sweeny, Dominick J Angiolillo, Francesco Franchi, et al.
International Journal of Antimicrobial Agents|November 12, 2017
Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coliDavid D Khan, Pernilla Lagerbäck, Christer Malmberg, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
The transcription factor TCF21 is necessary for adoption of cell fates by Foxd1+ stromal progenitors during kidney developmentGal Finer, Mohammad D Khan, Yalu Zhou, et al.
Clinical and Translational Gastroenterology|June 23, 2020
Longitudinal Renal Function in Liver Transplant Recipients With Acute-on-Chronic Liver FailureMasahiko Yazawa, Benedict Maliakkal, Satheesh Nair, et al.
Investigational New Drugs|January 19, 2010
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanomaEvan M Hersh, Steven J O'Day, John Powderly, et al.
Scientific Reports|May 22, 2024
Quantifying combined effects of colistin and ciprofloxacin against Escherichia coli in an in silico pharmacokinetic-pharmacodynamic modelChenyan Zhao, Anders N Kristoffersson, David D Khan, et al.
Pageof 20